Latest Sustainable Growth News

Talius Group has reported a net profit of $0.37 million for Q2 2025, driven by a 6% increase in subscriptions and strategic partnerships that expand its market reach in aged care technology.

Elsight Limited reports record-breaking revenue growth in Q2 and H1 2025, driven by major defence contracts and expanding market opportunities, positioning the company for profitability later this year.

One Click Group Limited has outpaced its entire July 2024 revenue within the first 18 days of July 2025, defying a broader decline in tax lodgements and showcasing strong customer loyalty.

Paladin Energy reports a 33% production surge at its Langer Heinrich Mine alongside a key environmental milestone for its Canadian project and announces a new CEO appointment. The company outlines strong FY2026 guidance amid ongoing operational ramp-up.

Westgold Resources capped FY25 with record quarterly gold production and a $132 million treasury boost, while announcing a maiden 2.3 million ounce resource at its Fletcher Zone.

Generation Development Group reports a transformative FY25 with record Investment Bond sales and successful integration of Evidentia and Lonsec managed accounts, setting the stage for strong growth in FY26.

Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.

BTC Health has secured a $0.5 million order for its life-saving ECMO equipment from the Women's and Children's Hospital in Adelaide, marking a significant expansion of its specialised medical device network alongside Melbourne's Royal Children's Hospital.

Qoria Limited reported a robust 25% year-on-year growth in annual recurring revenue, hitting $145 million, alongside a 670% jump in EBITDA and a positive free cash flow outlook for FY2026. The company’s expanding global footprint and strategic partnerships underpin its strong momentum.

Perpetual Limited reported a 2.5% increase in assets under management to A$226.8 billion for Q4 FY25, driven by strong market performance and inflows. The company reaffirmed its expense guidance and continues to pursue the sale of its Wealth Management business.

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

Qualitas Limited has announced the early release of over 30 million shares from voluntary escrow, significantly increasing the free float ahead of schedule and potentially enhancing market liquidity.